4.6 Article

Novel Small Molecule Inhibitors That Prevent the Neuroparalysis of Tetanus Neurotoxin

期刊

PHARMACEUTICALS
卷 14, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/ph14111134

关键词

tetanus neurotoxin; trafficking; disulfide reduction; thioredoxin system inhibitors; EGA

资金

  1. Italian Ministry of Defense [982]
  2. University of Padova

向作者/读者索取更多资源

Tetanus neurotoxin, produced by Clostridium tetani, causes deadly neuroparalysis. Vaccination prevents the disease, but it still exists in countries with low vaccination coverage. Inhibitors interfering with toxin trafficking show promise for developing therapeutics against tetanus.
Tetanus neurotoxin (TeNT) is a protein exotoxin produced by Clostridium tetani that causes the deadly spastic neuroparalysis of tetanus. It consists of a metalloprotease light chain and of a heavy chain linked via a disulphide bond. TeNT binds to the neuromuscular junction (NMJ) and it is retro-axonally transported into vesicular compartments to the spinal cord, where it is released and taken up by inhibitory interneuron. Therein, the catalytic subunit is translocated into the cytoplasm where it cleaves its target protein VAMP-1/2 with consequent blockage of the release of inhibitory neurotransmitters. Vaccination with formaldehyde inactivated TeNT prevents the disease, but tetanus is still present in countries where vaccination coverage is partial. Here, we show that small molecule inhibitors interfering with TeNT trafficking or with the reduction of the interchain disulphide bond block the activity of the toxin in neuronal cultures and attenuate tetanus symptoms in vivo. These findings are relevant for the development of therapeutics against tetanus based on the inhibition of toxin molecules that are being retro-transported to or are already within the spinal cord and are, thus, not accessible to anti-TeNT immunoglobulins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据